| Wendy Pyle, | |
|
1400 E Union St, Greenville, MS 38703-3246 | |
| (662) 378-3783 | |
| Not Available |
| Full Name | Wendy Pyle |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 13 Years |
| Location | 1400 E Union St, Greenville, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306108477 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R867456 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Dominic-jackson Memorial Hospital | Jackson, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physicians Anesthesia Group, P.a. | 6103806864 | 48 |
News Archive
Mast Therapeutics, Inc. today reported financial results for the fourth quarter and year ended December 31, 2013.
Phase 3 results presented today at The International Liver Congress 2015 show that a combination of daclatasvir (DCV), sofosbuvir (SOF) and ribavirin (RBV) for 12 weeks was effective and well tolerated amongst patients with hepatitis C virus (HCV) infection with advanced cirrhosis and post-transplant recurrence.
Elsevier, a world-leading publisher of scientific, technical and medical information products and solutions, is pleased to announce the launch of a new journal, Developmental Cognitive Neuroscience.
Seattle Genetics, Inc. today announced the initiation of a phase Ib clinical trial evaluating SGN-75 in combination with everolimus (Afinitor) for patients with advanced metastatic renal cell carcinoma (RCC).
A specific pattern of neuronal firing in a brain reward circuit instantly rendered mice vulnerable to depression-like behavior induced by acute severe stress, a study supported by the National Institutes of Health has found. When researchers used a high-tech method to mimic the pattern, previously resilient mice instantly succumbed to a depression-like syndrome of social withdrawal and reduced pleasure-seeking - they avoided other animals and lost their sweet tooth.
› Verified 9 days ago
| Entity Name | Physicians Anesthesia Group, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407890783 PECOS PAC ID: 6103806864 Enrollment ID: O20040722001098 |
News Archive
Mast Therapeutics, Inc. today reported financial results for the fourth quarter and year ended December 31, 2013.
Phase 3 results presented today at The International Liver Congress 2015 show that a combination of daclatasvir (DCV), sofosbuvir (SOF) and ribavirin (RBV) for 12 weeks was effective and well tolerated amongst patients with hepatitis C virus (HCV) infection with advanced cirrhosis and post-transplant recurrence.
Elsevier, a world-leading publisher of scientific, technical and medical information products and solutions, is pleased to announce the launch of a new journal, Developmental Cognitive Neuroscience.
Seattle Genetics, Inc. today announced the initiation of a phase Ib clinical trial evaluating SGN-75 in combination with everolimus (Afinitor) for patients with advanced metastatic renal cell carcinoma (RCC).
A specific pattern of neuronal firing in a brain reward circuit instantly rendered mice vulnerable to depression-like behavior induced by acute severe stress, a study supported by the National Institutes of Health has found. When researchers used a high-tech method to mimic the pattern, previously resilient mice instantly succumbed to a depression-like syndrome of social withdrawal and reduced pleasure-seeking - they avoided other animals and lost their sweet tooth.
› Verified 9 days ago
| Entity Name | Premier Anesthesia Of Mississippi Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033400197 PECOS PAC ID: 5597933036 Enrollment ID: O20110801000660 |
News Archive
Mast Therapeutics, Inc. today reported financial results for the fourth quarter and year ended December 31, 2013.
Phase 3 results presented today at The International Liver Congress 2015 show that a combination of daclatasvir (DCV), sofosbuvir (SOF) and ribavirin (RBV) for 12 weeks was effective and well tolerated amongst patients with hepatitis C virus (HCV) infection with advanced cirrhosis and post-transplant recurrence.
Elsevier, a world-leading publisher of scientific, technical and medical information products and solutions, is pleased to announce the launch of a new journal, Developmental Cognitive Neuroscience.
Seattle Genetics, Inc. today announced the initiation of a phase Ib clinical trial evaluating SGN-75 in combination with everolimus (Afinitor) for patients with advanced metastatic renal cell carcinoma (RCC).
A specific pattern of neuronal firing in a brain reward circuit instantly rendered mice vulnerable to depression-like behavior induced by acute severe stress, a study supported by the National Institutes of Health has found. When researchers used a high-tech method to mimic the pattern, previously resilient mice instantly succumbed to a depression-like syndrome of social withdrawal and reduced pleasure-seeking - they avoided other animals and lost their sweet tooth.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wendy Pyle, 313 Woodlake Dr, Brandon, MS 39047-6091 Ph: (601) 951-8939 | Wendy Pyle, 1400 E Union St, Greenville, MS 38703-3246 Ph: (662) 378-3783 |
News Archive
Mast Therapeutics, Inc. today reported financial results for the fourth quarter and year ended December 31, 2013.
Phase 3 results presented today at The International Liver Congress 2015 show that a combination of daclatasvir (DCV), sofosbuvir (SOF) and ribavirin (RBV) for 12 weeks was effective and well tolerated amongst patients with hepatitis C virus (HCV) infection with advanced cirrhosis and post-transplant recurrence.
Elsevier, a world-leading publisher of scientific, technical and medical information products and solutions, is pleased to announce the launch of a new journal, Developmental Cognitive Neuroscience.
Seattle Genetics, Inc. today announced the initiation of a phase Ib clinical trial evaluating SGN-75 in combination with everolimus (Afinitor) for patients with advanced metastatic renal cell carcinoma (RCC).
A specific pattern of neuronal firing in a brain reward circuit instantly rendered mice vulnerable to depression-like behavior induced by acute severe stress, a study supported by the National Institutes of Health has found. When researchers used a high-tech method to mimic the pattern, previously resilient mice instantly succumbed to a depression-like syndrome of social withdrawal and reduced pleasure-seeking - they avoided other animals and lost their sweet tooth.
› Verified 9 days ago
Michael Arnold, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1400 E Union St, Greenville, MS 38703 Phone: 662-378-3783 | |
Meredith Morris, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1400 E Union St, Greenville, MS 38703 Phone: 662-822-8534 | |
Robert Coleman, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1400 E Union St, Greenville, MS 38703 Phone: 662-378-3783 | |
David Neal Partrige, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1400 E Union St, Greenville, MS 38703 Phone: 662-725-2163 | |
Corey Auerswald, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1400 E Union St, Greenville, MS 38703 Phone: 662-725-2749 Fax: 662-725-3913 | |
Michelle Lowery, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1400 E Union St, Greenville, MS 38703 Phone: 662-378-3783 |